Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 250 results in range #301 to #550.
- 60S ribosomal protein L13 (1 revision)
- ABCB8 (1 revision)
- ALARA (1 revision)
- 60S ribosomal protein L10-like (1 revision)
- ALDOC (1 revision)
- ACOT1 (1 revision)
- 22q11.2 deletion syndrome case study one (1 revision)
- 8-cell stage (1 revision)
- ACER3 (1 revision)
- AAVS1 (1 revision)
- ALDH3B1 (1 revision)
- 60S ribosomal protein L29 (1 revision)
- ADAMTS8 (1 revision)
- 22q11.2 deletion syndrome echocardiography or ultrasound (1 revision)
- ALS Therapy Development Institute (1 revision)
- 60S ribosomal protein L28 (1 revision)
- ALIVE (1 revision)
- 60S ribosomal protein L12 (1 revision)
- AAK (1 revision)
- ANGPTL1 (1 revision)
- ACCN3 (1 revision)
- A2ML1 (1 revision)
- ACOT7 (1 revision)
- ALS2CR8 (1 revision)
- ACOT11 (1 revision)
- ACES (nutritional supplement) (1 revision)
- ADAMTS17 (1 revision)
- AM-087 (1 revision)
- ALX1 (1 revision)
- AP1M1 (1 revision)
- ADAM18 (1 revision)
- ABHD5 (1 revision)
- AM-938 (1 revision)
- 23andMe (1 revision)
- 24-Dehydrocholesterol reductase (1 revision)
- AMBN (1 revision)
- AMA Physician Masterfile (1 revision)
- 2C-B (1 revision)
- 2C-B-BZP (1 revision)
- 2C-B-FLY (1 revision)
- AMG-36 (1 revision)
- 2C-D (1 revision)
- AMG-1 (1 revision)
- AMOT (1 revision)
- AMOTL2 (1 revision)
- AMIGO (1 revision)
- 2C-I (1 revision)
- AMP deaminase (1 revision)
- AMPA receptor (1 revision)
- ANCA-associated vasculitides (1 revision)
- AMY1C (1 revision)
- ANKK1 (1 revision)
- ANKRD15 (1 revision)
- ANKRD13C (1 revision)
- ANKHD1 (1 revision)
- ANKRD25 (1 revision)
- ANKRD31 (1 revision)
- ANKRD27 (1 revision)
- ANKRD17 (1 revision)
- 2C-T-7 (1 revision)
- ANP32D (1 revision)
- ANOVA-simultaneous component analysis (1 revision)
- 2C-TFM (1 revision)
- ACSBG2 (1 revision)
- 2R hypothesis (1 revision)
- 2b3a (1 revision)
- 2nd Skin (1 revision)
- ACSF3 (1 revision)
- 2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane (1 revision)
- 2β-propanoyl-3β-(2-naphthyl)-tropane (1 revision)
- 2β-propanoyl-3β-(4-tolyl)-tropane (1 revision)
- AO/OTA classification for the distal tibial Fracture (1 revision)
- ANXA7 (1 revision)
- AP1GBP1 (1 revision)
- AOC2 (1 revision)
- 3,4-Diaminopyridine (1 revision)
- 3,4-Dimethylamphetamine (1 revision)
- AP4E1 (1 revision)
- ADAM12 (1 revision)
- 3-Aminoisobutyric acid (1 revision)
- 3-Aminopyridine (1 revision)
- AP4M1 (1 revision)
- 3-Hydroxyacyl ACP dehydrase (1 revision)
- APBA2BP (1 revision)
- ACSS3 (1 revision)
- 3-Methylcrotonyl-CoA carboxylase deficiency (1 revision)
- APBA3 (1 revision)
- API oil-water separator (1 revision)
- 3-Methylglutaconyl CoA (1 revision)
- APBB3 (1 revision)
- 3-Quinuclidinyl benzilate (1 revision)
- 3-Ureidopropionic acid (1 revision)
- 3-dehydrosphinganine reductase (1 revision)
- APC (gene) (1 revision)
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 revision)
- APOBEC2 (1 revision)
- ACS National Historical Chemical Landmarks (1 revision)
- 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (1 revision)
- 3-hydroxyisobutyrate dehydrogenase (1 revision)
- ARHGAP29 (1 revision)
- 3-methylglutaconic acid (1 revision)
- 310 helix (1 revision)
- APOBEC3H (1 revision)
- APOBEC4 (1 revision)
- 3C-P (1 revision)
- APOL1 (1 revision)
- 3T3-L1 (1 revision)
- 5-bromouracil (1 revision)
- 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective (1 revision)
- 3 hydroxyisobutyric aciduria (1 revision)
- 3 methylcrotonic aciduria (1 revision)
- 3c syndrome (1 revision)
- 3m syndrome (1 revision)
- APTX 4869 (1 revision)
- 3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane (1 revision)
- ARB Project (1 revision)
- 4,5-MDO-DMT (1 revision)
- 4,5-MDO-DiPT (1 revision)
- ACTL6B (1 revision)
- ARHGEF35 (1 revision)
- 4-Acetoxy-DET (1 revision)
- 4-Acetoxy-DIPT (1 revision)
- ARHGAP25 (1 revision)
- 4-Aminobiphenyl (1 revision)
- ACTL7A (1 revision)
- 4-Aminoquinoline (1 revision)
- 4-Androstene-3,6,17-trione (1 revision)
- ARHGAP9 (1 revision)
- ARL15 (1 revision)
- ARHGEF3 (1 revision)
- 4-Chloroindole-3-acetic acid (1 revision)
- ARHGEF4 (1 revision)
- 4-Dimethylaminophenol (1 revision)
- 4-HO-DBT (1 revision)
- 4-HO-DET (1 revision)
- 4-HO-DPT (1 revision)
- 4-HO-DiPT (1 revision)
- 4-HO-MET (1 revision)
- 4-HO-MPT (1 revision)
- 4-HO-pyr-T (1 revision)
- 4-Hydroxy-4-methylpentanoic acid (1 revision)
- ARIH2 (1 revision)
- ARIH1 (1 revision)
- 4-Hydroxytestosterone (1 revision)
- 4-MTA (1 revision)
- 4-MeO-MiPT (1 revision)
- 4-Methylbenzylidene camphor (1 revision)
- ARL6IP1 (1 revision)
- 4-Methylthioamphetamine (1 revision)
- 4-Nitroaniline (1 revision)
- ARMET (1 revision)
- 4-Oxalocrotonate tautomerase (1 revision)
- ACTR2 (1 revision)
- ASIC3 (1 revision)
- 40S (1 revision)
- ARREST (1 revision)
- 40S ribosomal protein S11 (1 revision)
- 40S ribosomal protein S12 (1 revision)
- 40S ribosomal protein S13 (1 revision)
- 40S ribosomal protein S14 (1 revision)
- 40S ribosomal protein S15a (1 revision)
- ARNT2 (1 revision)
- 40S ribosomal protein S18 (1 revision)
- 40S ribosomal protein S19 (1 revision)
- ASHRAE (1 revision)
- ACTR3B (1 revision)
- ACTR3 (1 revision)
- 40S ribosomal protein S23 (1 revision)
- 40S ribosomal protein S24 (1 revision)
- ARUP Laboratories (1 revision)
- 40S ribosomal protein S26 (1 revision)
- ASB1 (1 revision)
- 40S ribosomal protein S28 (1 revision)
- ASCL2 (1 revision)
- 40S ribosomal protein S3 (1 revision)
- ACVR1B (1 revision)
- 40S ribosomal protein S4, Y isoform 1 (1 revision)
- 40S ribosomal protein S4, Y isoform 2 (1 revision)
- 40S ribosomal protein S5 (1 revision)
- 40S ribosomal protein S7 (1 revision)
- 40S ribosomal protein S8 (1 revision)
- 40S ribosomal protein S9 (1 revision)
- 454 Life Sciences (1 revision)
- ACTIVE A Trial (1 revision)
- ATC code H05 (1 revision)
- ARMC9 (1 revision)
- ABCC2 (1 revision)
- ABCC4 (1 revision)
- 5'-3' exoribonuclease 1 (1 revision)
- Ф29 phage (1 revision)
- ACVR1C (1 revision)
- 5'-Phosphoribosylformylglycinamidine (1 revision)
- 5'-phosphoribosyl-4-carboxy-5-aminoimidazole (1 revision)
- 5'-phosphoribosyl-5-aminoimidazole (1 revision)
- 5' flanking region (1 revision)
- 5,10-Methylenetetrahydrofolate (1 revision)
- 5,6-MDO-DMT (1 revision)
- 5,6-MDO-DiPT (1 revision)
- 5,6-MDO-MiPT (1 revision)
- 5,6-MeO-MiPT (1 revision)
- ASZ1 (1 revision)
- ASTL (1 revision)
- 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
- ATC code A (1 revision)
- ASCC3 (1 revision)
- ACY1 (1 revision)
- ATC code H01 (1 revision)
- AD-36 (1 revision)
- ALDH1L1 (1 revision)
- ADAM11 (1 revision)
- AGPAT9 (1 revision)
- ADAM17 (1 revision)
- ADAM8 (1 revision)
- ADAMTS4 (1 revision)
- AFF3 (1 revision)
- ADAMTS9 (1 revision)
- ABT-239 (1 revision)
- 5-HT receptor (1 revision)
- 5-Hydroxyindoleacetic acid (1 revision)
- 5-Hydroxytryptophan (1 revision)
- 5-Lipoxygenase activating protein (1 revision)
- ADCC (1 revision)
- 5-MeO-AET (1 revision)
- ADCY10 (1 revision)
- 5-MeO-DALT (1 revision)
- 5-MeO-DET (1 revision)
- 5-MeO-DMT (1 revision)
- 5-MeO-DPT (1 revision)
- 5-MeO-MiPT (1 revision)
- 5-MeO-NMT (1 revision)
- 5-MeO-pyr-T (1 revision)
- 5-MeS-DMT (1 revision)
- 5-Methoxy-diisopropyltryptamine (1 revision)
- 5-Methylcytosine (1 revision)
- 5-Methylindole (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
- AIP (gene) (1 revision)
- ACCN1 (1 revision)
- AGPAT5 (1 revision)
- 5-alpha-reductase deficiency case study one (1 revision)
- AFTPH (1 revision)
- 60S ribosomal protein L37 (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- ACAT2 (1 revision)
- 5-alpha-reductase deficiency electrocardiogram (1 revision)
- ALDH1B1 (1 revision)
- 5-alpha-reductase deficiency future or investigational therapies (1 revision)
- ACBD3 (1 revision)
- AGXT2 (1 revision)